Active investors chose Healthy Young Minds as the Pitch Perfect winner at the INVEST Digital Health Conference in Dallas. See how the company’s CEO accepted the award. The post Video: INVEST Digital Health Pitch Perfect Winner Accepting Award appeared first on MedCity News.
This policy watch looks at the major new Ebola outbreak in DRC, discusses how the U.S. government has responded so far, and describes how the current situation compares to prior U.S. Ebola responses.
This brief presents five key facts about Medicaid coverage among individuals living in rural areas. It draws on recent data to describe enrollment patterns, differences by state Medicaid expansion status, characteristics of the rural Medicaid population, and patterns of health care use among enrollees.
As individual enrollment grows, agents must evolve to meet a more complex, consumer-driven market. The post Individual Coverage Is Reshaping Health Insurance. Agents Are the Key to Making It Work appeared first on MedCity News.
While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with higher doses, the company and analysts are interested in the drug’s potential to be combined with Novo Nordisk’s Wegovy. Skye’s drug is an antibody designed to preferentially target CB1 receptors in the gut, offering an alternative approach to activating GLP-1…
HPV self-collection testing empowers more people to participate in their own care, fostering autonomy and helping to bridge long-standing gaps in access to screenings for all populations. The post Empowering Prevention: The Present and Future of Cervical Cancer Screening appeared first on MedCity News.
This policy watch examines the USAID list of terminated awards, recently sent Congress, to examine the implications for global health programs and outstanding questions.
It’s Matthew Holt and I am looking forward to MC-ing the #LeagueConnectDigitalSummit THIS Wednesday May 7. This one-day virtual event brings together leaders across health care, tech, and consumer experience to explore what it really takes to deliver personalized, digital-first, AI-powered care. I’ll be guiding the day’s key transitions and themes. There’s also strategy &…
Kathy Saunders, senior vice president of revenue cycle management at Redefine, speaks about partnership with AI orchestration company Adonis
Pharvaris’s deucrictibant met the main and secondary goals of its Phase 3 test as an on-demand treatment for swelling attacks caused by the rare disease hereditary angioedema. Pharvaris’s capsule could compete against Kalvista Pharmaceuticals’ Ekterly, an HAE pill approved by the FDA over the summer. The post Pharvaris Drug for Rare Swelling Disease Meets Phase…